Find Diclofenac Potassium manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

FDF DossiersDRUG PRODUCT COMPOSITIONS

296RELATED EXCIPIENT COMPANIES

483EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

GLOBAL SALES INFORMATION

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 15307-81-0, Cataflam, Cgp 45840b, Voltfast, Cambia, Zipsor
Molecular Formula
C14H10Cl2KNO2
Molecular Weight
334.2  g/mol
InChI Key
KXZOIWWTXOCYKR-UHFFFAOYSA-M
FDA UNII
L4D5UA6CB4

Diclofenac Potassium
A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
1 2D Structure

Diclofenac Potassium

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
potassium;2-[2-(2,6-dichloroanilino)phenyl]acetate
2.1.2 InChI
InChI=1S/C14H11Cl2NO2.K/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;/h1-7,17H,8H2,(H,18,19);/q;+1/p-1
2.1.3 InChI Key
KXZOIWWTXOCYKR-UHFFFAOYSA-M
2.1.4 Canonical SMILES
C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[K+]
2.2 Other Identifiers
2.2.1 UNII
L4D5UA6CB4
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Dichlofenal

2. Diclofenac

3. Diclofenac Sodium

4. Diclofenac, Sodium

5. Diclonate P

6. Diclophenac

7. Dicrofenac

8. Feloran

9. Gp 45,840

10. Gp-45,840

11. Gp45,840

12. Novapirina

13. Orthofen

14. Orthophen

15. Ortofen

16. Sodium Diclofenac

17. Sr 38

18. Sr-38

19. Sr38

20. Voltaren

21. Voltarol

2.3.2 Depositor-Supplied Synonyms

1. 15307-81-0

2. Cataflam

3. Cgp 45840b

4. Voltfast

5. Cambia

6. Zipsor

7. Diclofenac Potassium [usan:usp]

8. Potassium Diclofenac

9. Potassium;2-[2-(2,6-dichloroanilino)phenyl]acetate

10. Diclofenac (potassium)

11. Cgp-45840b

12. Diclofenac Potassium Salt

13. L4d5ua6cb4

14. Chebi:4508

15. Benzeneacetic Acid, 2-((2,6-dichlorophenyl)amino)-, Monopotassium Salt

16. Potassium 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate

17. Cataflam; Diclofenac Potassium; K-fenak; Potassium Diclofenac; Prosorb

18. Diclofenac Potassium [usan]

19. Unii-l4d5ua6cb4

20. Cataflam (tn)

21. Potassium (o-(2,6-dichloroanilino)phenyl)acetate

22. Cambia (tn)

23. Zipsor (tn)

24. Diclofenac Potassium (usp)

25. Schembl40784

26. Chembl1200804

27. Dtxsid30165212

28. Hms3656d18

29. Diclofenac Potassium [vandf]

30. Diclofenac Potassium [mart.]

31. S3062

32. Diclofenac Potassium [usp-rs]

33. Diclofenac Potassium [who-dd]

34. Akos015889752

35. Akos015994733

36. Diclofenac Potassium Salt [mi]

37. Ccg-267848

38. Ks-5037

39. Ac-18735

40. Diclofenac Potassium [orange Book]

41. Hy-15038

42. Diclofenac Potassium [ep Monograph]

43. Db-043176

44. Diclofenac Potassium [usp Monograph]

45. Cs-0003712

46. Ft-0603076

47. Sw196404-4

48. D00903

49. Q27106401

50. Potassium {2-[(2,6-dichlorophenyl)amino]phenyl}acetate

51. Potassium 2-(2-(2,6-dichlorophenylamino)phenyl)acetate

52. Potassium (o-((2,6-dichlorophenyl)amino)phenyl)acetate

53. 2-((2,6-dichlorophenyl)amino)benzeneacetic Acid, Monopotassium Salt

2.4 Create Date
2008-02-05
3 Chemical and Physical Properties
Molecular Weight 334.2 g/mol
Molecular Formula C14H10Cl2KNO2
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count4
Exact Mass332.9725654 g/mol
Monoisotopic Mass332.9725654 g/mol
Topological Polar Surface Area52.2 Ų
Heavy Atom Count20
Formal Charge0
Complexity310
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 8  
Drug NameCambia
Drug LabelCAMBIA (Diclofenac Potassium for Oral Solution) is a benzeneacetic acid derivative NSAID. CAMBIA is available as a buffered soluble powder, designed to be mixed with water prior to oral administration. CAMBIA is a white to off-white, buff...
Active IngredientDiclofenac potassium
Dosage FormFor solution
RouteOral
Strength50mg
Market StatusPrescription
CompanyDepomed

2 of 8  
Drug NameCataflam
PubMed HealthDiclofenac
Drug ClassesAnalgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent
Drug LabelCataflam (diclofenac potassium immediate-release tablets) is a benzeneacetic acid derivative. Cataflam is available as immediate-release tablets of 50 mg (light brown) for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benz...
Active IngredientDiclofenac potassium
Dosage FormTablet
RouteOral
Strength50mg
Market StatusPrescription
CompanyNovartis

3 of 8  
Drug NameDiclofenac potassium
Drug LabelDiclofenac potassium tablets USP are a benzeneacetic acid derivative. Diclofenac potassium tablets USP, 50 mg are available as orange, film-coated tablets for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benzeneacetic acid,...
Active IngredientDiclofenac potassium
Dosage FormTablet
RouteOral
Strength50mg
Market StatusPrescription
CompanyTeva; Apotex; Sandoz; Mylan

4 of 8  
Drug NameZipsor
PubMed HealthDiclofenac
Drug ClassesAnalgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent
Drug LabelZipsor (diclofenac potassium) Liquid Filled Capsule is a benzeneacetic acid derivative NSAID. Zipsor is available as liquid-filled capsules of 25 mg for oral administration. The chemical name is 2-[(2,6- dichlorophenyl) amino] benzeneacetic acid mono...
Active IngredientDiclofenac potassium
Dosage FormCapsule
RouteOral
Strength25mg
Market StatusPrescription
CompanyDepomed

5 of 8  
Drug NameCambia
Drug LabelCAMBIA (Diclofenac Potassium for Oral Solution) is a benzeneacetic acid derivative NSAID. CAMBIA is available as a buffered soluble powder, designed to be mixed with water prior to oral administration. CAMBIA is a white to off-white, buff...
Active IngredientDiclofenac potassium
Dosage FormFor solution
RouteOral
Strength50mg
Market StatusPrescription
CompanyDepomed

6 of 8  
Drug NameCataflam
PubMed HealthDiclofenac
Drug ClassesAnalgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent
Drug LabelCataflam (diclofenac potassium immediate-release tablets) is a benzeneacetic acid derivative. Cataflam is available as immediate-release tablets of 50 mg (light brown) for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benz...
Active IngredientDiclofenac potassium
Dosage FormTablet
RouteOral
Strength50mg
Market StatusPrescription
CompanyNovartis

7 of 8  
Drug NameDiclofenac potassium
Drug LabelDiclofenac potassium tablets USP are a benzeneacetic acid derivative. Diclofenac potassium tablets USP, 50 mg are available as orange, film-coated tablets for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benzeneacetic acid,...
Active IngredientDiclofenac potassium
Dosage FormTablet
RouteOral
Strength50mg
Market StatusPrescription
CompanyTeva; Apotex; Sandoz; Mylan

8 of 8  
Drug NameZipsor
PubMed HealthDiclofenac
Drug ClassesAnalgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent
Drug LabelZipsor (diclofenac potassium) Liquid Filled Capsule is a benzeneacetic acid derivative NSAID. Zipsor is available as liquid-filled capsules of 25 mg for oral administration. The chemical name is 2-[(2,6- dichlorophenyl) amino] benzeneacetic acid mono...
Active IngredientDiclofenac potassium
Dosage FormCapsule
RouteOral
Strength25mg
Market StatusPrescription
CompanyDepomed

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Anti-Inflammatory Agents, Non-Steroidal

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)


Cyclooxygenase Inhibitors

Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Cyclooxygenase Inhibitors [MoA]; Decreased Prostaglandin Production [PE]; Nonsteroidal Anti-inflammatory Drug [EPC]; Anti-Inflammatory Agents, Non-Steroidal [CS]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - 25MG **Federal Registe...DOSAGE - TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 20142

read-more

DOSAGE - TABLET;ORAL - 50MG **Federal Registe...DOSAGE - TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 20142

read-more

DOSAGE - CAPSULE;ORAL - 25MG

USFDA APPLICATION NUMBER - 22202

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Taste Masking

read-more
read-more

Solubilizers

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Parenteral

read-more
read-more

Controlled & Modified Release

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Topical

read-more
read-more

Co-Processed Excipients

read-more
read-more

Lubricants & Glidants

read-more
read-more

Empty Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Emulsifying Agents

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Vegetarian Capsules

read-more
read-more

Coloring Agents

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Looking for 15307-81-0 / Diclofenac Potassium API manufacturers, exporters & distributors?

Diclofenac Potassium manufacturers, exporters & distributors 1

68

PharmaCompass offers a list of Diclofenac Potassium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diclofenac Potassium manufacturer or Diclofenac Potassium supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diclofenac Potassium manufacturer or Diclofenac Potassium supplier.

PharmaCompass also assists you with knowing the Diclofenac Potassium API Price utilized in the formulation of products. Diclofenac Potassium API Price is not always fixed or binding as the Diclofenac Potassium Price is obtained through a variety of data sources. The Diclofenac Potassium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Diclofenac Potassium

Synonyms

15307-81-0, Cataflam, Cgp 45840b, Voltfast, Cambia, Zipsor

Cas Number

15307-81-0

Unique Ingredient Identifier (UNII)

L4D5UA6CB4

About Diclofenac Potassium

A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.

Diclofenac Potassium Manufacturers

A Diclofenac Potassium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diclofenac Potassium, including repackagers and relabelers. The FDA regulates Diclofenac Potassium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diclofenac Potassium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Diclofenac Potassium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Diclofenac Potassium Suppliers

A Diclofenac Potassium supplier is an individual or a company that provides Diclofenac Potassium active pharmaceutical ingredient (API) or Diclofenac Potassium finished formulations upon request. The Diclofenac Potassium suppliers may include Diclofenac Potassium API manufacturers, exporters, distributors and traders.

click here to find a list of Diclofenac Potassium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Diclofenac Potassium USDMF

A Diclofenac Potassium DMF (Drug Master File) is a document detailing the whole manufacturing process of Diclofenac Potassium active pharmaceutical ingredient (API) in detail. Different forms of Diclofenac Potassium DMFs exist exist since differing nations have different regulations, such as Diclofenac Potassium USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Diclofenac Potassium DMF submitted to regulatory agencies in the US is known as a USDMF. Diclofenac Potassium USDMF includes data on Diclofenac Potassium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diclofenac Potassium USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Diclofenac Potassium suppliers with USDMF on PharmaCompass.

Diclofenac Potassium KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Diclofenac Potassium Drug Master File in Korea (Diclofenac Potassium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Diclofenac Potassium. The MFDS reviews the Diclofenac Potassium KDMF as part of the drug registration process and uses the information provided in the Diclofenac Potassium KDMF to evaluate the safety and efficacy of the drug.

After submitting a Diclofenac Potassium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Diclofenac Potassium API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Diclofenac Potassium suppliers with KDMF on PharmaCompass.

Diclofenac Potassium CEP

A Diclofenac Potassium CEP of the European Pharmacopoeia monograph is often referred to as a Diclofenac Potassium Certificate of Suitability (COS). The purpose of a Diclofenac Potassium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Diclofenac Potassium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Diclofenac Potassium to their clients by showing that a Diclofenac Potassium CEP has been issued for it. The manufacturer submits a Diclofenac Potassium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Diclofenac Potassium CEP holder for the record. Additionally, the data presented in the Diclofenac Potassium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Diclofenac Potassium DMF.

A Diclofenac Potassium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Diclofenac Potassium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Diclofenac Potassium suppliers with CEP (COS) on PharmaCompass.

Diclofenac Potassium WC

A Diclofenac Potassium written confirmation (Diclofenac Potassium WC) is an official document issued by a regulatory agency to a Diclofenac Potassium manufacturer, verifying that the manufacturing facility of a Diclofenac Potassium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Diclofenac Potassium APIs or Diclofenac Potassium finished pharmaceutical products to another nation, regulatory agencies frequently require a Diclofenac Potassium WC (written confirmation) as part of the regulatory process.

click here to find a list of Diclofenac Potassium suppliers with Written Confirmation (WC) on PharmaCompass.

Diclofenac Potassium NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diclofenac Potassium as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Diclofenac Potassium API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Diclofenac Potassium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Diclofenac Potassium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diclofenac Potassium NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Diclofenac Potassium suppliers with NDC on PharmaCompass.

Diclofenac Potassium GMP

Diclofenac Potassium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Diclofenac Potassium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diclofenac Potassium GMP manufacturer or Diclofenac Potassium GMP API supplier for your needs.

Diclofenac Potassium CoA

A Diclofenac Potassium CoA (Certificate of Analysis) is a formal document that attests to Diclofenac Potassium's compliance with Diclofenac Potassium specifications and serves as a tool for batch-level quality control.

Diclofenac Potassium CoA mostly includes findings from lab analyses of a specific batch. For each Diclofenac Potassium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Diclofenac Potassium may be tested according to a variety of international standards, such as European Pharmacopoeia (Diclofenac Potassium EP), Diclofenac Potassium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diclofenac Potassium USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty